✦ LIBER ✦

9005 Vandetanib versus erlotinib in patients with previously treated advanced non-small-cell lung cancer (NSCLC): a randomized, double-blind phase III trial

✍ Scribed by Goss, G.D.; Thongprasert, S.; Greco, F.A.; Thomas, M.; Tsai, C.M.; Sunpaweravong, P.; Ferry, D.; Gogov, S.; Rowbottom, J.A.; Natale, R.B.

Book ID: 123094444
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 48 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71718-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III Trial of Vandetanib Compared W

Phase III Trial of Vandetanib Compared With Erlotinib in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

✍ Natale, R. B.; Thongprasert, S.; Greco, F. A.; Thomas, M.; Tsai, C.-M.; Sunpawer 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 298 KB

9001 Vandetanib plus docetaxel versus do

9001 Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (NSCLC): a randomized, double-blind phase III trial

✍ Eberhardt, W.E.E.; Johnson, B.E.; Sun, Y.; Germonpré, P.; Saijo, N.; Zhou, C.; W 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Randomized, Double-Blind, Placebo-Contro

Randomized, Double-Blind, Placebo-Controlled, Phase II Trial of Sorafenib and Erlotinib or Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer

✍ Spigel, D. R.; Burris, H. A.; Greco, F. A.; Shipley, D. L.; Friedman, E. K.; Wat 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 161 KB

9004 Vandetanib plus pemetrexed vs pemet

9004 Vandetanib plus pemetrexed vs pemetrexed as 2nd-line therapy in patients with advanced non-small-cell lung cancer (NSCLC): a randomized, double-blind phase III trial

✍ Vansteenkiste, J.; Arrieta, O.; Gottfried, M.; Blackhall, F.H.; Raats, J.; Yang, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

9174 Phase II study of everolimus plus e

9174 Phase II study of everolimus plus erlotinib in previously treated patients with advanced non-small cell lung cancer (NSCLC)

✍ Soria, J.C.; Bennouna, J.; Leighl, N.; Khuri, F.; Traynor, A.M.; Johnson, B.; Ka 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Randomized Phase III Trial of Pemetrexed

Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy

✍ Hanna, N.; Shepherd, F. A.; Fossella, F. V.; Pereira, J. R.; De Marinis, F.; von 📂 Article 📅 2004 🏛 American Society of Clinical Oncology 🌐 English ⚖ 229 KB